iShares Neuroscience and Healthcare ETF (IBRN)
NYSEARCA: IBRN · Real-Time Price · USD
25.90
+0.39 (1.52%)
At close: Sep 5, 2025, 4:00 PM
25.90
0.00 (0.00%)
After-hours: Sep 5, 2025, 8:00 PM EDT
IBRN Holdings Information
IBRN is an equity ETF with a total of 63 individual holdings. The top holdings are Supernus Pharmaceuticals stock at 5.06%, argenx SE at 4.70%, Xenon Pharmaceuticals at 4.58%, ACADIA Pharmaceuticals at 4.35%, and SK Biopharmaceuticals at 4.33%.
Total Holdings
63
Top 10 Percentage
42.81%
Asset Class
Equity
ETF Category
Health
Assets
3.78M
PE Ratio
16.14
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SUPN | Supernus Pharmaceuticals, Inc. | 5.06% |
| 2 | ARGX | argenx SE | 4.70% |
| 3 | XENE | Xenon Pharmaceuticals Inc. | 4.58% |
| 4 | ACAD | ACADIA Pharmaceuticals Inc. | 4.35% |
| 5 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 4.33% |
| 6 | NBIX | Neurocrine Biosciences, Inc. | 4.20% |
| 7 | PTCT | PTC Therapeutics, Inc. | 4.19% |
| 8 | BIIB | Biogen Inc. | 3.95% |
| 9 | DNLI | Denali Therapeutics Inc. | 3.77% |
| 10 | HLUNB.CO | H. LUNDBECK CLASS B | 3.68% |
| 11 | SRRK | Scholar Rock Holding Corporation | 3.57% |
| 12 | ALKS | Alkermes plc | 3.42% |
| 13 | BHVN | Biohaven Ltd. | 3.01% |
| 14 | ASX: NEU | Neuren Pharmaceuticals Limited | 2.98% |
| 15 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.88% |
| 16 | AVDL | Avadel Pharmaceuticals plc | 2.78% |
| 17 | STO: BIOA.B | BioArctic AB (publ) | 2.75% |
| 18 | STO: DYVOX | Dynavox Group AB (publ) | 2.52% |
| 19 | DYN | Dyne Therapeutics, Inc. | 2.37% |
| 20 | EWTX | Edgewise Therapeutics, Inc. | 2.37% |
| 21 | IART | Integra LifeSciences Holdings Corporation | 2.16% |
| 22 | TYO: 4592 | SanBio Company Limited | 1.84% |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 1.76% |
| 24 | AVXL | Anavex Life Sciences Corp. | 1.62% |
| 25 | SRPT | Sarepta Therapeutics, Inc. | 1.61% |
As of Sep 4, 2025